IceCure Medical Ltd. Ordinary Shares (ICCM) Stock Price

ICCMStock

$1.06−95.72%52W

Market Cap$4.92M

P/E—

PEG Ratio—

Div yield—

Beta0.48

ICCM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-99.94%

Price vs S&P 500 (4W)-44.32%

VGM Score38.61

Book Value / Share (Quarterly)$3.47

P/TBV (Annual)1.33x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)3.03%

Cash Flow / Share (Quarterly)$-4.65

Price vs S&P 500 (YTD)-106.13%

Gross Margin (TTM)36.10%

Net Profit Margin (TTM)-427.67%

EPS (TTM)$-6.73

10-Day Avg Trading Volume0.22M

EPS Excl Extra (TTM)$-6.73

Revenue Growth (5Y)-2.68%

EPS (Annual)$-7.11

ROI (Annual)-166.36%

Gross Margin (Annual)36.28%

Net Profit Margin (5Y Avg)-430.69%

Cash / Share (Quarterly)$3.51

Revenue Growth QoQ (YoY)72.76%

ROA (Last FY)-108.42%

Revenue Growth TTM (YoY)41.62%

EBITD / Share (TTM)$-6.49

ROE (5Y Avg)-122.46%

Operating Margin (TTM)-423.69%

Cash Flow / Share (Annual)$-5.99

P/B Ratio0.31x

P/B Ratio (Quarterly)1.40x

Net Income / Employee (Annual)$-224,700

EV / Revenue (TTM)-2.13x

Net Interest Coverage (TTM)-69.75x

ROA (TTM)-112.58%

EPS Incl Extra (Annual)$-7.11

Current Ratio (Annual)2.61x

Quick Ratio (Quarterly)2.15x

3-Month Avg Trading Volume2.37M

52-Week Price Return-95.72%

Revenue / Employee (TTM)$58,900

Tangible BV / Share (Quarterly)$0.48

P/S Ratio (Annual)1.07x

Asset Turnover (Annual)0.24x

52-Week High$26.10

Operating Margin (5Y Avg)-436.51%

EPS Excl Extra (Annual)$-7.11

CapEx CAGR (5Y)-30.37%

26-Week Price Return-90.04%

Quick Ratio (Annual)1.96x

13-Week Price Return-70.96%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.88x

Enterprise Value$-8.40M

Revenue / Share Growth (5Y)47.82%

Asset Turnover (TTM)0.26x

Revenue / Employee (Annual)$50,400

Inventory Turnover (Annual)0.93x

Pretax Margin (Annual)-445.61%

Cash / Share (Annual)$3.65

3-Month Return Std Dev71.33%

Gross Margin (5Y Avg)44.14%

Net Income / Employee (TTM)$-251,900

ROE (Last FY)-166.36%

Net Interest Coverage (Annual)-106.52x

EPS Basic Excl Extra (Annual)$-7.11

Receivables Turnover (TTM)14.76x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-6.73

Receivables Turnover (Annual)12.24x

ROI (TTM)-174.26%

P/S Ratio (TTM)0.92x

Pretax Margin (5Y Avg)-430.69%

Revenue / Share (Annual)$1.59

Tangible BV / Share (Annual)$0.56

Price vs S&P 500 (52W)-111.25%

Year-to-Date Return-94.21%

5-Day Price Return-1.85%

EPS Normalized (Annual)$-7.11

ROA (5Y Avg)-81.28%

Net Profit Margin (Annual)-445.61%

Month-to-Date Return-34.37%

Cash Flow / Share (TTM)$-0.41

EBITD / Share (Annual)$-6.98

Operating Margin (Annual)-446.70%

ROI (5Y Avg)-122.46%

EPS Basic Excl Extra (TTM)$-6.73

P/TBV (Quarterly)1.53x

P/B Ratio (Annual)4.63x

Inventory Turnover (TTM)1.03x

Pretax Margin (TTM)-427.67%

Book Value / Share (Annual)$3.71

Price vs S&P 500 (13W)-73.64%

Beta0.48x

Revenue / Share (TTM)$1.28

ROE (TTM)-174.26%

52-Week Low$0.96

gGradeB

mGradeF

vgmGradeD

ICCM Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 12, 2026	-$1.38	-$1.37	+0.36%(+$0.01)
Q1 2026	May 12, 2026	-$1.20	-$1.80	-50.00%(-$0.60)
Q4 2025	Mar 17, 2026	-$1.20	-$1.80	-50.00%(-$0.60)
Q3 2025	Nov 19, 2025	-$1.65	-$1.80	-9.09%(-$0.15)
Q2 2025	Aug 13, 2025	-$1.95	-$1.80	+7.69%(+$0.15)

ICCM Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.11

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
ICCMIceCure Medical Ltd. Ordinary Shares	—	B	F	0.9x	-2.7%	36.1%	-423.7%	$1.06
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About IceCure Medical Ltd. Ordinary Shares

Icecure Medical develops minimally invasive cryoablation systems using liquid nitrogen to treat solid tumors across multiple indications, including breast, lung, kidney, and bone cancers. The company's technology offers patients an alternative to traditional surgical intervention with reduced recovery time and lower risk. As a commercial-stage company, Icecure is focused on expanding adoption of its cryoablation platform across oncology markets.